alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 19.11-8 Required elections between survivor benefits. ( a ) *Bar against concurrent payment under this Act and Workers' Compensation Act.* Except as stated below, survivor annuities and survivors' compensation for work injuries under 5 U.S.C. 8102 are not payable concurrently if both are based on the death of the same employee. A survivor entitled to both must elect which of the two benefits he/she prefers. Should all eligible survivors of a deceased employee elect to receive the compensation benefit rather than the survivor annuity, their rights to the latter are terminated and, if the lump-sum credit has not been exhausted, a lump-sum payment will become due under § 19.13. The one exception to this rule occurs when a widow or widower is being paid the balance of a scheduled compensation award under 5 U.S.C. 8107 due the deceased employee. If so, the widow or widower may receive the survivor annuity and compensation award concurrently.
( b ) *Election between survivor annuity and social security benefits.* Pursuant to 42 U.S.C. 417 (a) and (e), survivors who are eligible for annuity which is based in part on military service performed by a principal between September 16, 1940, and December 31, 1956, and also for survivor benefits under the Social Security system, may elect to have the military service credited toward the Social Security benefit. In practice, the survivors should apply for both benefits, ask the Department and the Social Security Administration for statements showing the amount of each benefit, and then make their election of where to credit the military service. If Social Security benefits are elected, the rights of *all* survivors to a foreign service annuity are terminated.
**Exhibit 31.1****Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer**I, James H. Long, certify that:1. I have reviewed this quarterly report on Form 10-Q of INX Inc.;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) forthe registrant and have:a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under my supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to me by others withinthose entities, particularly during the period in which this report is being prepared;b) Designed such internal control over financial reporting, or caused such internal control overfinancial reporting to be designed under our supervision, to provide reasonable assuranceregarding the reliability of financial reporting and the preparation of financial statements forexternal purposes in accordance with generally accepted accounting principles;c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report my conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; andd) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control over financialreporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or persons performing the equivalent functions):a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; andb) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.        Date: May 5, 2008 By:  /s/ JAMES H. LONG    James H. Long, Chief Executive Officer
Exhibit 31.4

CERTIFICATION

I, Kevin D. Green, certify
that:



|1. | I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of Cerus Corporation; and
|-- | -----------------------------------------------------------------------------------------------------



|2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                         |  |  |  |  |  |                                                                                  
|------------------------ |  |  |  |  |  | ---------------------------------------------------------------------------------
|Date: September 22, 2014 |  |  |  |  |  | /s/ Kevin D. Green                                                               
|                         |  |  |  |  |  | Kevin D. Green                                                                   
|                         |  |  |  |  |  | Vice President, Finance and Chief Financial Officer (Principal
Financial Officer)
§ 38.707 Hearings. ( a ) A designated contract market must adopt rules that provide for the following minimum requirements for any hearing conducted pursuant to a notice of charges: ( 1 ) The hearing must be fair, must be conducted before members of the disciplinary panel, and must be promptly convened after reasonable notice to the respondent. The formal rules of evidence need not apply; nevertheless, the procedures for the hearing may not be so informal as to deny a fair hearing. No member of the disciplinary panel for the matter may have a financial, personal, or other direct interest in the matter under consideration.
( 2 ) In advance of the hearing, the respondent must be entitled to examine all books, documents, or other evidence in the possession or under the control of the designated contract market. The designated contract market may withhold documents that are privileged or constitute attorney work product, documents that were prepared by an employee of the designated contract market but will not be offered in evidence in the disciplinary proceedings, documents that may disclose a technique or guideline used in examinations, investigations, or enforcements proceedings, and documents that disclose the identity of a confidential source.
( 3 ) The designated contract market's enforcement and compliance staffs must be parties to the hearing, and the enforcement staff must present their case on those charges and sanctions that are the subject of the hearing.
( 4 ) The respondent must be entitled to appear personally at the hearing, must be entitled to cross-examine any persons appearing as witnesses at the hearing, and must be entitled to call witnesses and to present such evidence as may be relevant to the charges.
( 5 ) The designated contract market must require persons within its jurisdiction who are called as witnesses to participate in the hearing and to produce evidence. It must make reasonable efforts to secure the presence of all other persons called as witnesses whose testimony would be relevant.
( 6 ) If the respondent has requested a hearing, a copy of the hearing must be made and must become a part of the record of the proceeding. The record must be one that is capable of being accurately transcribed; however, it need not be transcribed unless the transcript is requested by Commission staff or the respondent, the decision is appealed pursuant to the rules of the designated contract market, or is reviewed by the Commission pursuant to section 8c of the Act or part 9 of this chapter. In all other instances a summary record of a hearing is permitted.
( b ) [Reserved]
Power of Attorney


Know all by these presents, that the undersigned (the "Reporting Person")
hereby constitutes and appoints each of Melanie A. DeMorrow, Assistant Vice
President-Shareholder Relations; Richard M. Lavers, Secretary; Joseph P.
Tomczak, Executive Vice President & C.F.O.; Kathy Samovitz, Associate
Counsel; and Jessica L. Long, Assistant Secretary,  signing singly, as the
Reporting Person's true and lawful attorney-in-fact, to:

(1) execute for and on behalf of the Reporting Person, in the Reporting
Person's capacity as an officer or trustee of Coachmen Industries, Inc.
(the "Company"), Forms 3, 4, and 5 and such other similar forms as may be
required for filing in accordance with Section 16(a) of the Securities
Exchange Act of 1934, or the Sarbanes-Oxley Act of 2002, and the rules
thereunder;

(2) do and perform all acts for and on behalf of the Reporting Person
which may be necessary or desirable to complete and execute any such forms
and timely file such forms with the United States Securities and Exchange
Commission and any stock exchange or similar authority or other federal
agency; and

(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, and in the best interest of, or legally required by, the Reporting
Person.

The Reporting Person hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the Reporting Person
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-facts substitute or substitutes, shall lawfully do or cause to
be done by the virtue of this Power of Attorney and the rights and powers
herein granted.  The Reporting Person acknowledges that the foregoing
attorneys-in fact, in serving in such capacity at the request of the Reporting
Person, are not assuming, nor is the company assuming, any of the Reporting
Persons responsibilities to comply with any of the above specified laws or
regulations.

This Power of Attorney shall remain in full force and effect until the
Reporting Person is no longer required to file such forms with respect to the
Reporting Person's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the Reporting Person in a signed writing
delivered to the Secretary of  the Company.

IN WITNESS WHEREOF, the Reporting Person has caused this Power of Attorney to
be executed as of this 17th day of June, 2004.



						s/Geoffrey B. Bloom
#### § 1413.3 Definition of meeting.

For purposes of this part, *meeting* shall mean the deliberations of at least two (2) members of the Board where such deliberations determine or result in the joint conduct or disposition of official agency business, but does not include deliberations to determine whether a meeting should be closed to public observation in accordance with the provisions of this part.
### §1875a. National Science Foundation Nonrecurring Expenses Fund

There is hereby established in the Treasury of the United States a fund to be known as the "National Science Foundation Nonrecurring Expenses Fund" (the Fund). Unobligated balances of expired discretionary funds appropriated for this or any succeeding fiscal year from the General Fund of the Treasury to the National Science Foundation by this or any other Act may be transferred (not later than the end of the fifth fiscal year after the last fiscal year for which such funds are available for the purposes for which appropriated) into the Fund. Amounts deposited in the Fund shall be available until expended, and in addition to such other funds as may be available for such purposes, for information and business technology system modernization and facilities infrastructure improvements, including nonrecurring maintenance, necessary for the operation of the Foundation or its funded research facilities, subject to approval by the Office of Management and Budget. Amounts in the Fund may be obligated only after the Committees on Appropriations of the House of Representatives and the Senate are notified at least 15 days in advance of the planned use of funds.

(Pub. L. 117–328, div. B, title III, Dec. 29, 2022, 136 Stat. 4551.)

#### **Editorial Notes**

#### Codification

Section was enacted as part of the Science Appropriations Act, 2023, and also as part of the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023, and the Consolidated Appropriations Act, 2023, and not as part of the National Science Foundation Act of 1950 which comprises this chapter.
#### § 41.2 Required records.

A designated contract market that trades a security index or security futures product shall maintain in accordance with the requirements of § 1.31 of this chapter books and records of all activities related to the trading of such products, including: Records related to any determination under subpart B of this part whether or not a futures contract on a security index is a narrow-based security index or a broad-based security index.

[77 FR 66344, Nov. 2, 2012]
§ 230.04 Guarantee eligibility. ( a ) Eligible Notes only are guaranteed hereunder. Notes in order to achieve Eligible Note status: ( 1 ) Must be signed on behalf of the Borrower, manually or in facsimile, by a duly authorized representative of the Borrower;
( 2 ) Must contain a certificate of authentication manually executed by a Fiscal Agent whose appointment by the Borrower is consented to by USAID in the Fiscal Agency Agreement; and
( 3 ) Shall be approved and authenticated by USAID by either: ( i ) The affixing by USAID on the Notes of a guarantee legend incorporating these Standard Terms and Conditions signed on behalf of USAID by either a manual signature or a facsimile signature of an authorized representative of USAID or
( ii ) The delivery by USAID to the Fiscal Agent of a guarantee certificate incorporating these Standard Terms and Conditions signed on behalf of USAID by either a manual signature or a facsimile signature of an authorized representative of USAID.
( b ) The authorized USAID representatives for purposes of this regulation whose signature(s) shall be binding on USAID shall include the USAID Chief and Deputy Chief Financial Officer, Assistant Administrator and Deputy, Bureau for Economic Growth, Agriculture and Trade, Director and Deputy Director, Office of Development Credit, and such other individual(s) designated in a certificate executed by an authorized USAID Representative and delivered to the Fiscal Agent. The certificate of authentication of the Fiscal Agent issued pursuant to the Fiscal Agency Agreement shall, when manually executed by the Fiscal Agent, be conclusive evidence binding on USAID that an Eligible Note has been duly executed on behalf of the Borrower and delivered.
#### Santo Sorrentino, Respondent, v. General Electric Company, Appellant.

All concur. (Appeal from an order granting plaintiff’s motion for a preference in a negligence action.) Present — Taylor, P. J., Kimball, Piper and Wheeler, JJ.
[Federal Register Volume 69, Number 27 (Tuesday, February 10, 2004)]
[Notices]
[Page 6314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-2767]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group, Microbiology and Infectious Diseases Research 
Committee.
    Date: February 25-27, 2004.
    Time: 8 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Gary S. Madonna, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, NIH, Room 2149, 6700-B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892-7616, Bethesda, MD 20892-7616. 301-496-3528; 
<a href="/cdn-cgi/l/email-protection#37505a06054077595e5f19505841"><span class="__cf_email__" data-cfemail="ec8b81ddde9bac828584c28b839a">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and funding 
cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS.)

    Dated: February 4, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-2767 Filed 2-9-04; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
### §1862v. National Science Foundation research

#### (a) In general

The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health and the Director of the National Institute of Mental Health and taking into consideration prioritized research agendas or strategic plans, as appropriate, shall, subject to the availability of appropriations, award grants on a competitive, merit-reviewed basis to institutions of higher education (or consortia of such institutions) to support multidisciplinary, fundamental research with potential relevance to suicide, including potential relevance to prevention and treatment, including, but not limited to—

(1) basic understanding of human social behavior;

(2) the neural basis of human cognition;

(3) basic understanding of cognitive, linguistic, social, cultural, and biological processes related to human development across the lifespan;

(4) basic understanding of perceptual, motor, and cognitive processes, and their interaction, in typical human behavior; and

(5) basic understanding of the relevance of drug and alcohol abuse.

#### (b) Encouraging applications from early career researchers

To promote the development of early career researchers, in awarding funds under subsection (a), the Director of the National Science Foundation shall encourage applications submitted by early career researchers, including doctoral students or postdoctoral researchers.

(Pub. L. 116–339, §3, Jan. 13, 2021, 134 Stat. 5126.)

#### **Editorial Notes**

#### Codification

Section was enacted as part of the Advancing Research to Prevent Suicide Act, and not as part of the National Science Foundation Act of 1950 which comprises this chapter.

#### **Statutory Notes and Related Subsidiaries**

#### Findings

Pub. L. 116–339, §2, Jan. 13, 2021, 134 Stat. 5126, provided that: "Congress finds the following:

"(1) The rate of Americans dying by suicide is on the rise, increasing 10.7 to 14.0 deaths per 100,000 people from 2001 to 2017.

"(2) Suicide is the tenth-leading cause of death among people in the United States and the second-leading cause of death for young people between the ages of 15 and 34.

"(3) The National Science Foundation funds research that is improving our basic understanding of factors with potential relevance to suicide, including potential relevance to prevention and treatment.

"(4) Despite progress in mental health research, current gaps exist in scientific understanding and basic knowledge of human neural, genetic, cognitive, perceptual, behavioral, social, and environmental factors with potential relevance to suicide."
[Federal Register Volume 69, Number 25 (Friday, February 6, 2004)]
[Notices]
[Page 5832]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-2747]


=======================================================================
-----------------------------------------------------------------------

BROADCASTING BOARD OF GOVERNORS


Sunshine Act Meeting

Date and Time: February 11, 2004; 1 p.m.-4 p.m.

Place: Cohen Building, Room 3321, 330 Independence Ave., SW., 
Washington, DC 20237.

Closed Meeting: The members of the Broadcasting Board of Governors 
(BBG) will meet in closed session to review and discuss a number of 
issues relating to U.S. Government-funded non-military international 
broadcasting. They will address internal procedural, budgetary, and 
personnel issues, as well as sensitive foreign policy issues relating 
to potential options in the U.S. international broadcasting field. This 
meeting is closed because if open it likely would either disclose 
matters that would be properly classified to be kept secret in the 
interest of foreign policy under the appropriate executive order (5 
U.S.C. 552b.(c)(1)) or would disclose information the premature 
disclosure of which would be likely to significantly frustrate 
implementation of a proposed agency action. (5 U.S.C. 552b.(c)(9)(B)). 
In addition, part of the discussion will relate solely to the internal 
personnel and organizational issues of the BBG or the International 
Broadcasting Bureau. (5 U.S.C. 552b.(c)(2) and (6))

FOR FURTHER INFORMATION CONTACT: Persons interested in obtaining more 
information should contact either Brenda Hardnett or Carol Booker at 
(202) 401-3736.

    Dated: February 4, 2004.
Carol Booker,
Legal Counsel.
[FR Doc. 04-2747 Filed 2-04-04; 3:30 pm]
BILLING CODE 8320-01-M